News tagged ‘StemCellTransplant’ clear
A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases.
Tags: BasicResearch, StemCellTransplant
- A Dana-Farber study challenges the hypothesis that "cancer stem cells" —
a small number of self-renewing cells within a tumor — are responsible
for breast cancer progression and recurrence, and that wiping out these
cells alone could cure the disease.
Tags: BreastCancer, StemCellTransplant
- An analysis of two dozen clinical studies finds most adults with
poor-risk and intermediate-risk acute myeloid leukemia benefit from
allogeneic stem cell transplants.
Tags: BasicResearch, StemCellTransplant, Leukemia
- Researchers report that patients with high-risk acute AML who received a
cancer vaccine after a stem cell transplant had few complications and
mounted a strong immune system attack on the disease.
Tags: StemCellTransplant, Leukemia
The pre-cancerous blood disorder myelodsysplastic syndrome (MDS) affects between 35,000 and 55,000 people in the United States. Dana-Farber's David Steensma, MD, discusses MDS and its treatment.
Tags: StemCellTransplant, Leukemia
Dana-Farber researchers have developed a method for determining how ready acute myeloid leukemia cells are to die, a finding that may enable oncologists to choose more effective treatments for their patients.
Tags: BasicResearch, StemCellTransplant, Leukemia
Almost two-thirds of children who receive stem cell transplants are readmitted to the hospital within six months, according to researchers at Dana-Farber/Children’s Hospital Cancer Center in Boston.
Tags: ChildhoodCancer, StemCellTransplant
Dana-Farber researchers found that an experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen of care, but that the new combination could provide an alternative that could be preferable in certain scenarios.
Tags: GraftVersusHost, StemCellTransplant, Leukemia
An innovative experimental treatment for boosting the effectiveness of stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies, according to Dana-Farber's Wolfram Goessling, MD, PhD.
Tags: StemCellTransplant
- A novel drug proved more effective than standard treatment in patients
who had life-threatening blockages in tiny blood vessels in the liver
following stem-cell transplants.
Tags: StemCellTransplant